Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 18/20 | 0.39 |
| ▸ | SLC5A1 | P13866 | 16/20 | 0.39 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4279646 | 0.89 | SLC5A2 (0.46) | SLC5A2SLC5A1 | |
| SCHEMBL4010805 | 0.84 | SLC5A2 (0.55) | SLC5A2SLC5A1SLC28A3 | |
| SCHEMBL4010809 | 0.84 | SLC5A2 (0.55) | SLC5A2SLC5A1SLC28A3 | |
| SCHEMBL4279751 | 0.84 | SLC5A2 (0.44) | SLC5A2SLC5A1 | |
| SCHEMBL4284185 | 0.82 | SLC5A2 (0.43) | SLC5A2SLC5A1 | |
| SCHEMBL4289217 | 0.80 | SLC5A2 (0.45) | SLC5A2SLC5A1 | |
| SCHEMBL4288474 | 0.79 | SLC5A2 (0.44) | SLC5A2SLC5A1 | |
| SCHEMBL4285520 | 0.79 | ACHE (0.44) | SLC5A2SLC5A1SLC28A3 | |
| SCHEMBL4001687 | 0.78 | SLC28A3 (0.59) | SLC5A2SLC5A1SLC28A3 | |
| SCHEMBL4001695 | 0.78 | SLC28A3 (0.59) | SLC5A2SLC5A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-2048150-A1 | BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | SLC5A2 2/4885SLC5A1 1/4885SLC28A3 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.